3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
5
Neoplasm Metastasis
2
Osteoporotic Fractures
1
Osteoporosis
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Musculoskeletal Pain
1
Arthralgia
1
Interventions
Blood Specimen Collection
6
Trastuzumab
2
Liquid Biopsy
2
Cyclophosphamide
2
Carboplatin
2
ribociclib
1
pertuzumab
1
eribulin
1
Zoledronic Acid
1
Watchful Waiting
1
Thiotepa
1
Surgical Procedures, Operative
1
Stem Cell Transplantation
1
Standard of Care
1
Reverse Transcriptase Polymerase Chain Reaction
1
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
Microfluidics
1
Letrozole
1
Lapatinib
1
Fulvestrant
1
Flow Cytometry
1
Epirubicin
1
Diphosphonates
1
Digoxin
1
Denosumab
1
Biopsy
1
Atorvastatin
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplastic Cells, Circulating
×
Diphosphonates
×
Breast
×
Clear all
NCT01129336
2014-05-20
MACS1295
Novartis
Phase 4
Completed
44 enrolled
10 charts